ReviewFrontiers in cell and developmental biology2024

Diverse perspectives on proteomic posttranslational modifications to address EGFR-TKI resistance in non-small cell lung cancer.

Yuhong Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.